DPP4 and Wilson disease: In the present investigation, we tested whether administering linagliptin (LGT), a long acting and specific DPP-4 inhibitor, to female C57BL/6 J mice fed a WD for 4 months, could ameliorate the development of WD-induced aortic and endothelial cell (EC) stiffness.